Skip to main content
Premium Trial:

Request an Annual Quote

PrimeSyn Lab Registers with FDA to Sell DNA Probes as ASRs

NEW YORK, Oct. 24 (GenomeWeb News) PrimeSyn Lab has registered with the US Food and Drug Administration to sell its DNA-based products as analyte-specific reagents, the company said in a statement dated Oct. 12.


PrimeSyn said in the statement that it is registered as a medical device manufacturer for custom DNA probes and primers used as analyte specific reagent products for in vitro diagnostic manufacturers.


The company can provide the ASRs to manufacturers without applying for any other approvals from the FDA, PrimeSyn told GenomeWeb News.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.